Tempest Therapeutics, Inc. has announced a definitive agreement to sell 739,000 shares of its common stock to a single institutional investor at an offering price of $6.25 per share, expected to ...
Tempest Therapeutics Inc. (NASDAQ:TPST) shares tumbled 12.9% in premarket trading on Tuesday after the biotech firm announced a registered direct offering aimed at raising roughly $4.25 million. The ...
BRISBANE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (TPST), a clinical-stage biotechnology company with a pipeline of first-in-class 1 targeted and immune-mediated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results